Borderline nuclear change, high-grade dyskaryosis not excluded: current concepts and impact on clinical practice

Cytopathology ◽  
2011 ◽  
Vol 23 (6) ◽  
pp. 396-401 ◽  
Author(s):  
S. Soo Hoo ◽  
A. Patel ◽  
H. Buist ◽  
K. Galaal ◽  
J. D. Hemming ◽  
...  
Keyword(s):  
Clinical Practice ◽  
High Grade ◽  
Nuclear Change

Clinicopathological significance of borderline nuclear change - high grade dyskaryosis not excluded

Cytopathology ◽  
2004 ◽  
Vol 15 (1) ◽  
pp. 18-24 ◽  
Author(s):  
C. Brodie ◽  
R. Kapur ◽  
M. Murray ◽  
L. Turner ◽  
D. Magee ◽  
...  
Keyword(s):  
High Grade ◽  
Nuclear Change ◽  
Clinicopathological Significance

scholarly journals P1.07-018 Incidence of Brain Recurrence and Survival Outcomes in High-Grade Neuroendocrine Carcinomas of the Lung: Implications for Clinical Practice

2017 ◽  
Vol 12 (1) ◽  
pp. S706-S707
Author(s):  
Giannis Mountzios ◽  
Biagio Ricciuti ◽  
Rita Chiari ◽  
Marina Baretti ◽  
Lorenzo Falcinelli ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Survival Outcomes ◽  
High Grade ◽  
Neuroendocrine Carcinomas

Proffered papers 
9.30-10.00 Monday 15 September 2003 2 Clinicopathologic significance of the ‘borderline nuclear change - high grade dyskaryosis not excluded’ report

Cytopathology ◽  
2003 ◽  
Vol 14 ◽  
pp. 4-4
Author(s):  
Brodie Caroline ◽  
Kapur Ritu ◽  
Murray Mary ◽  
Magee Derek ◽  
Turner Lesley ◽  
...  
Keyword(s):  
High Grade ◽  
Nuclear Change

Is mRNA indeed Useful in Clinical Management of Cervical Pathology?

2021 ◽  
pp. 121-128
Author(s):  
Panagiotis Cherouveim ◽  
Antonios Athanasiou ◽  
Evangelos Paraskevaidis
Keyword(s):  
Clinical Practice ◽  
Precision Medicine ◽  
Clinical Management ◽  
Screening Test ◽  
Personalised Medicine ◽  
Added Value ◽  
High Grade ◽  
Hpv Testing ◽  
Advantages And Disadvantages ◽  
Comparative Advantages

Personalised medicine and precision medicine are being applied in more medical fields in the last years. The need for personalisation is especially pronounced in cervical pathology, since in the majority of cases an abnormal screening test does not necessarily imply high-grade lesion, regardless of whether the screening test is cytology or HPV testing. The chapter aims to summarize the exact added value that mRNA presents for management in clinical practice as well as highlight comparative advantages and disadvantages with other triage strategies.

Platinum-etoposide chemotherapy for extra-pulmonary high grade neuroendocrine carcinoma (EP-G3-NEC): A survey of clinical practice

2017 ◽  
Author(s):  
Angela Lamarca ◽  
Melissa Frizziero ◽  
Jorge Barriuso ◽  
Mairead G McNamara ◽  
Richard A Hubner ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Neuroendocrine Carcinoma ◽  
High Grade ◽  
Extra Pulmonary

Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice

Lung Cancer ◽  
2016 ◽  
Vol 95 ◽  
pp. 82-87 ◽  
Author(s):  
Giulio Metro ◽  
Biagio Ricciuti ◽  
Rita Chiari ◽  
Marina Baretti ◽  
Lorenzo Falcinelli ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Survival Outcomes ◽  
High Grade ◽  
Neuroendocrine Carcinomas

scholarly journals Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline

2014 ◽  
Vol 21 (3) ◽  
pp. 493 ◽  
Author(s):  
X. Kostaras ◽  
F. Cusano ◽  
G.A. Kline ◽  
W. Roa ◽  
J. Easaw
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
High Grade Glioma ◽  
High Grade
Sign in / Sign up

Export Citation Format

Share Document